Le Lézard
Classified in: Health, Covid-19 virus

Leading Healthcare Executives Discuss Their Experiences with COVID-19


NAPA, Calif., Aug. 5, 2020 /PRNewswire/ -- In the midst of the COVID-19 pandemic, leading healthcare executives will meet today in a two-hour virtual Executive Advisory Board meeting sponsored by The Doctors Company to discuss their shared experiences, lessons learned, and the path forward.

This meeting takes place against a backdrop of unprecedented pressures on clinical and supporting staff, the peak demand for intensive care, and the overwhelming challenge of dealing with a potentially lethal virus with no history of causing human disease. All these factors have stretched the nation's healthcare system to its limit.  

In a pre-meeting survey, the Executive Advisory Board members, leaders of some of America's best healthcare facilities, noted their issues of greatest concern were:

  1. Understanding the lessons learned to date in caring for COVID-19 patients.
  2. The role of telehealth today and beyond the pandemic.
  3. Actions underway to provide broad medical liability protection for those heroically innovating diagnosis and treatment plans against this devastating illness.

The Executive Advisory Board meeting is a national summit of representatives of industry-leading organizations brought together by The Doctors Company to discuss the most pressing issues in healthcare.

"This discussion with top healthcare leaders demonstrates the extraordinary impact not only on those battling the disease itself, but in the disruption of medical care for nearly all illness," said Richard E. Anderson, MD, FACP, chairman and CEO of The Doctors Company. "These life and death battles are being fought by a medical workforce pushed to human limits even as many medical facilities have been rendered inaccessible, and are compounded by the billions of dollars in operating losses already incurred. They rightfully seek protection against litigation, second guessing the battlefield decisions that have been required day after day after day."

"Eventually this scourge will be defeated, and we look forward to continuing our dialogue with healthcare leaders on their vision for the future of medicine after COVID-19," Dr. Anderson added. "We will use this opportunity to further our mission to advance, protect, and reward the practice of good medicine."

About The Doctors Company
Founded and led by physicians, The Doctors Company (thedoctors.com) is relentlessly committed to advancing, protecting, and rewarding the practice of good medicine. The Doctors Company takes the mal out of malpractice insurance by helping hospitals and practices of all sizes manage the complexities of today's healthcare environment?with expert guidance, resources, and coverage. The Doctors Company is the nation's largest physician-owned medical malpractice insurer, with 80,000 members and $5.9 billion in assets, and is rated A by A.M. Best Company and Fitch Ratings. To learn more about data-driven insights and to stay up to date on industry trends, follow and subscribe to The Doctors Company on Twitter (@doctorscompany), YouTubeLinkedIn, and Facebook.

SOURCE The Doctors Company


These press releases may also interest you

at 07:15
CureVac N.V. ("CureVac"), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mRNA"), will report financial results, and provide business updates for the...

at 07:00
Revive Therapeutics Ltd. ("Revive" or the "Company") , a specialty life sciences company focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders, announced today...

at 07:00
BEYFORTUS® (nirsevimab) is the first long-acting antibody approved in Canada for the prevention of Respiratory Syncytial Virus (RSV) lower respiratory tract disease in neonates and infants through their first RSV season.iBEYFORTUS® is also approved...

at 07:00
NioCorp Developments Ltd. ("NioCorp" or the "Company") plans to investigate the feasibility of recycling permanent rare earth magnets as part of NioCorp's proposed Elk Creek Critical Minerals Project (the "Elk Creek...

at 06:45
On April 17, FAIR Health hosted a webinar entitled "Fifteen Years of Advancing Health Literacy and Cost Transparency: A Free Webinar on FAIR Health's Award-Winning Consumer Resources." This webinar offered a comprehensive review of FAIR Health's...

at 06:38
"According to the latest research study, the demand for Biologic Therapeutic Drugs: Technologies and Global Markets expected to grow from $452.9 in 2023 to reach $823.4 billion by the end of 2028 at a compound annual growth rate (CAGR) of 12.7%...



News published on and distributed by: